Pantoprazole Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Proton pump inhibitor in the prevention of upper gastrointestinal mucosal injury associated with dual antiplatelet therapy after coronary artery bypass grafting (DACAB-GI-2): study protocol for a randomized controlled trial
This study aims to compare the efficacy and safety of 12 months and 1 month of pantoprazole treatment in preventing DAPT-related upper gastrointestinal mucosal injury after CABG.Trial registrationClinicalTrials.gov NCT03908593. (Source: Trials)
Source: Trials - July 15, 2022 Category: Research Source Type: clinical trials

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
Conditions:   Pancreatic Cancer;   Pancreas Cancer;   Ampullary Cancer;   Pancreas Neuroendocrine Tumor;   Pancreatitis;   Distal Extrahepatic Cholangiocarcinoma;   Duodenal Cancer Interventions:   Drug: Placebo;   Drug: Pantoprazole Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2022 Category: Research Source Type: clinical trials